Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hypotension 1Breast Neoplasms 1Bradycardia 1

Interventions

Fulvestrant 67Letrozole 57Paclitaxel 54pembrolizumab 42Trastuzumab 42ribociclib 39palbociclib 37Specimen Handling 37Capecitabine 36Anastrozole 35Carboplatin 34Tamoxifen 33abemaciclib 32exemestane 31pertuzumab 29Magnetic Resonance Spectroscopy 27Cyclophosphamide 27trastuzumab deruxtecan 25Radiotherapy 22Surveys and Questionnaires 21Blood Specimen Collection 20Biopsy 19olaparib 18Standard of Care 17Docetaxel 17Taxes 15130-nm albumin-bound paclitaxel 15eribulin 14Methods 14Mastectomy, Segmental 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Levobupivacaine × 90 days × Clear all
NCT02004834 2026-05-04

Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine

University Hospital Dubrava

Phase 4 Active not recruiting
80 enrolled
Breast

Bradycardia, Breast Neoplasms, Hypotension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡